Selected Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2018

Selected Quarterly Financial Information (Unaudited)

Schedule of unaudited consolidated financial results of operations

(amounts in thousands, except per share data)	March 31		June 30		September 30		December 31
2018 Quarter Ended
Revenues	$	7,551	$	847	$	461	$	797
Operating expenses		(20,415)		(18,554)		(53,386)		(31,676)
Loss from operations		(12,864)		(17,707)		(52,925)		(30,879)
Other income (expense)		28		(129)		(51)		(204)
Income tax (expense) benefit		(506)		48		151		259
Net loss		(13,342)		(17,788)		(52,825)		(30,824)
Basic and diluted loss per share	$	(0.36)	$	(0.44)	$	(0.90)	$	(0.46)
2017 Quarter Ended
Revenues	$	1,678	$	1,051	$	1,468	$	1,122
Operating expenses		(16,878)		(16,613)		(22,193)		(23,403)
Loss from operations		(15,200)		(15,562)		(20,725)		(22,281)
Other income (expense)		326		(7)		328		120
Income tax (expense) benefit		(349)		967		(1,872)		(101)
Net loss		(15,223)		(14,602)		(22,269)		(22,262)
Basic and diluted loss per share (1)	$	(0.56)	$	(0.54)	$	(0.79)	$	(0.61)

(1) Net loss per share amounts may not agree to the per share amounts for the full year due to the use of weighted average shares for each period. Additionally, loss per share for the quarter ended March 31, 2017 is recast to reflect the Redomicilation Transaction, accordingly the loss per share presented is based on the equivalent number of Nabriva Ireland ordinary shares outstanding in all periods.